Clinical Efficacy of Stereotactic Radiotherapy and Microwave Ablation for Liver Metastases From Colorectal Cancer.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Fei U Xu, M Med
Peking University Third Hospital
Study Director - Fuxin Guo, MD
Peking University Third Hospital
Principal Investigator - Hui Xie, MD
Beijing 302 Hospital
Principal Investigator - Jing Sun, M Med
Beijing 302 Hospital
Principal Investigator - Junjie U Wang, MD
Peking University Third Hospital
Study Chair - Kaixian Zhang, MD
Tengzhou Central People's Hospital
Principal Investigator - Wei Li, MD
Beijing Ditan Hospital
Principal Investigator - Xian Xu, M Med
Hunan Aerospace Hospital
Principal Investigator - Xuezhang Duan, MD
Beijing 302 Hospital
Principal Investigator - Zuping Lian, MD
Guangxi Ruikang Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Beijing Ditan Hospital
Beijing, Beijing Municipality, China
Recruiting - Peking University Third Hospital
Beijing, Beijing Municipality, China
Fei XuFuxin GuoJunjie Wang, ChairmanRecruiting - the Fifth Medical Center of Pla General Hospital
Beijing, Beijing Municipality, China
Hui XieJing SunXuezhang DuanRecruiting - Guangxi Ruikang Hospital
Nanning, Guangxi, China
Recruiting - Hunan Aerospace Hospital
Changsha, Hunan, China
Recruiting - Tengzhou Central People'S Hospital
Tengzhou, Shandong, China
Kaixian Zhang, directorRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Jun 2019
- Primary completion
- 31 May 2021
- Completion
- 31 May 2022
- Last update posted
- 19 Jul 2019
- Registered enrollment
- 100
- Registry id
- NCT03963726
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.